Innoviva (INVA) Short Interest Ratio & Short Volume → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free INVA Stock Alerts $15.56 +0.03 (+0.19%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Innoviva Short Interest DataCurrent Short Volume11,520,000 sharesPrevious Short Volume11,330,000 sharesChange Vs. Previous Month+1.68%Dollar Volume Sold Short$165.89 millionShort Interest Ratio / Days to Cover16.7Last Record DateApril 15, 2024Outstanding Shares63,230,000 sharesFloat Size62,420,000 sharesShort Percent of Float18.46%Today's Trading Volume332,496 sharesAverage Trading Volume659,344 sharesToday's Volume Vs. Average50% Short Selling Innoviva ? Sign up to receive the latest short interest report for Innoviva and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINVA Short Interest Over TimeINVA Days to Cover Over TimeINVA Percentage of Float Shorted Over Time Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. Innoviva Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,520,000 shares $165.89 million +1.7%18.5%16.7 $14.40 3/31/202411,330,000 shares $172.67 million -13.0%18.2%16.6 $15.24 3/15/202413,020,000 shares $193.48 million -2.3%20.9%19.4 $14.86 2/29/202413,320,000 shares $203.53 million +7.9%21.3%17.8 $15.28 2/15/202412,350,000 shares $197.60 million +1.3%19.5%17.3 $16.00 1/31/202412,190,000 shares $197.48 million +3.3%19.2%17.5 $16.20 Get the Latest News and Ratings for INVA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innoviva and its competitors with MarketBeat's FREE daily newsletter. 1/15/202411,800,000 shares $193.17 million -6.8%22.3%15.6 $16.37 12/31/202312,660,000 shares $203.07 million +5.0%20.0%16 $16.04 12/15/202312,060,000 shares $186.81 million +10.2%19.0%15.4 $15.49 11/30/202310,940,000 shares $151.52 million +13.8%17.3%15 $13.85 11/15/20239,610,000 shares $133.29 million +7.1%15.2%14.4 $13.87 10/31/20238,970,000 shares $111.32 million +5.8%14.2%13.9 $12.41 10/15/20238,480,000 shares $112.87 million -3.5%13.2%14.2 $13.31 9/30/20238,790,000 shares $114.18 million +0.9%13.7%15.8 $12.99 9/15/20238,710,000 shares $109.40 million -0.1%13.5%16.6 $12.56 8/31/20238,720,000 shares $111.18 million +1.9%13.5%16 $12.75 8/15/20238,560,000 shares $118.90 million +2.0%13.3%14.4 $13.89 7/31/20238,390,000 shares $113.68 million -4.9%13.1%12.7 $13.55 7/15/20238,820,000 shares $110.07 million +0.5%13.7%13.6 $12.48 6/30/20238,780,000 shares $111.77 million -14.8%13.6%13.1 $12.73 6/15/202310,300,000 shares $135.65 million +3.7%16.0%14.6 $13.17 5/31/20239,930,000 shares $133.96 million +10.7%15.4%14.4 $13.49 5/15/20238,970,000 shares $115.80 million +1.7%13.9%12.3 $12.91 4/30/20238,820,000 shares $103.46 million +0.1%13.1%13 $11.73 4/15/20238,810,000 shares $105.90 million +1.6%13.1%12.3 $12.02 3/31/20238,670,000 shares $97.54 million -2.3%12.9%12.1 $11.25 3/15/20238,870,000 shares $101.38 million +5.9%13.2%12.6 $11.43 2/28/20238,380,000 shares $101.15 million -3.6%12.2%12.5 $12.07 2/15/20238,690,000 shares $108.10 million -2.9%12.6%14.2 $12.44 1/31/20238,950,000 shares $113.22 million -5.2%13.0%14.3 $12.65 1/15/20239,440,000 shares $126.21 million -4.2%13.7%16.1 $13.37 12/30/20229,850,000 shares $130.51 million -3.8%14.2%17.4 $13.25 12/15/202210,240,000 shares $132.71 million -1.6%14.8%17.5 $12.96 11/30/202210,410,000 shares $136.68 million +0.7%15.0%17.7 $13.13 11/15/202210,340,000 shares $138.45 million +3.2%14.9%16.1 $13.39 10/31/202210,020,000 shares $135.87 million -1.9%14.5%15.8 $13.56 10/15/202210,210,000 shares $135.08 million -2.0%14.8%15.3 $13.23 9/30/202210,420,000 shares $120.98 million -5.2%15.1%14.6 $11.61 9/15/202210,990,000 shares $136.94 million -5.0%15.9%14.1 $12.46 8/31/202211,570,000 shares $152.26 million +2.8%16.7%14.4 $13.16The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read INVA Short Interest - Frequently Asked Questions What is Innoviva's current short interest? Short interest is the volume of Innoviva shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,520,000 shares of INVA short. 18.46% of Innoviva's shares are currently sold short. Learn More on Innoviva's current short interest. What is a good short interest ratio for Innoviva? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INVA shares currently have a short interest ratio of 17.0. Learn More on Innoviva's short interest ratio. What is a good short interest percentage for Innoviva? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.46% of Innoviva's floating shares are currently sold short. Is Innoviva's short interest increasing or decreasing? Innoviva saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 11,520,000 shares, an increase of 1.7% from the previous total of 11,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Innoviva's float size? Innoviva currently has issued a total of 63,230,000 shares. Some of Innoviva's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Innoviva currently has a public float of 62,420,000 shares. How does Innoviva's short interest compare to its competitors? 18.46% of Innoviva's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Innoviva: OPKO Health, Inc. (23.81%), MannKind Co. (13.21%), Ironwood Pharmaceuticals, Inc. (13.96%), Ligand Pharmaceuticals Incorporated (4.98%), Phathom Pharmaceuticals, Inc. (43.45%), Kiniksa Pharmaceuticals, Ltd. (5.13%), Theravance Biopharma, Inc. (14.72%), Lexicon Pharmaceuticals, Inc. (8.17%), Dynavax Technologies Co. (14.17%), Vanda Pharmaceuticals Inc. (3.80%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Innoviva stock? Short selling INVA is an investing strategy that aims to generate trading profit from Innoviva as its price is falling. INVA shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Innoviva? A short squeeze for Innoviva occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INVA, which in turn drives the price of the stock up even further. How often is Innoviva's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INVA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OPK Short Interest Data MNKD Short Interest Data IRWD Short Interest Data LGND Short Interest Data PHAT Short Interest Data KNSA Short Interest Data TBPH Short Interest Data LXRX Short Interest Data DVAX Short Interest Data VNDA Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INVA) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press